COO vs SRPT · P/E 36, rev $4.09B vs rev $1.13B
The Cooper Companies, Inc (COO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
COO currently screens at market cap $14.92B and trailing P/E 36.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the COO and SRPT stock pages for the full models.
Not investment advice.